The Home Study: Pharmacy-Access Contingency Planning for Chronic-Illness Patients: A Pharmacist Counseling Framework
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)
University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Joint Provider(s)
Jase Medical
(H) Pharmacy-Access Contingency Planning for Chronic-Illness Patients: A Pharmacist Counseling Framework
(H) Pharmacy-Access Contingency Planning for Chronic-Illness Patients: A Pharmacist Counseling Framework
Chronic-illness patients are the highest-volume users of outpatient prescription medications and the population most affected when medication access is disrupted. Documented disruption patterns include insulin rationing under cost pressure and recent manufacturer-driven insulin analog discontinuations, rescue inhaler access gaps among nebulizer-dependent patients during a documented, ongoing supply shortage, anticoagulant interruption during travel and hospitalization, and antidepressant continuity gaps during extended international assignments. Disease-specific guidelines from ADA, GOLD, the ACC/AHA valvular heart disease guideline, and ASHP establish the clinical importance of continuous therapy, yet pharmacist counseling at dispense rarely addresses what the patient should do when access is disrupted. The refill window is the touchpoint where contingency planning is most actionable, and pharmacist counseling at that touchpoint is rarely structured. The purpose of this application-based activity is to equip pharmacists with a documented counseling framework for pharmacy-access contingency planning in chronic-illness patients, supporting both individual patient outcomes and population-level chronic-disease management.
Objectives
- Use chronic-disease management guidance (ADA Standards of Care in Diabetes, the GOLD Report, the 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease) to identify chronic-illness patients at elevated risk for medication-access disruption.
- Determine which chronic-disease therapies require contingency planning based on disease severity, therapy criticality, supply chain vulnerability, and patient-specific access conditions.
- Practice counseling techniques for pharmacy-access contingency strategies, including extended supply (where allowed), backup medication identification, dose-adjustment limits, and escalation pathways for the patient's specific therapy.
- Implement a documented pharmacy-access contingency conversation as part of routine refill or new-prescription dispensing for high-risk chronic-illness patients.
Speaker(s)/Author(s)
|
Jamie Wilkey, PharmD, RPh
|
Activity Number
0064-9999-26-056-H01-P
Release Date:
Aug 10, 2026
Credit Expiration Date:
Aug 10, 2029
CE Hours
1.00